We are live on ! Find out more
APP

Avantax Planning Partners Portfolio holdings

AUM $4.02B
1-Year Est. Return 20%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+20%
3 Year Est. Return
+51.05%
5 Year Est. Return
+51.22%
10 Year Est. Return
AUM
$2.79B
AUM Growth
-$323M
Cap. Flow
-$496M
Cap. Flow %
-17.8%
Top 10 Hldgs %
54.72%
Holding
493
New
23
Increased
52
Reduced
324
Closed
50
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIV icon
51
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
$9.05M 0.32%
115,519
-20,805
-15% -$1.6M
MRK icon
52
Merck
MRK
$316B
$8.86M 0.32%
77,991
-19,675
-20% -$2.34M
IWP icon
53
iShares Russell Mid-Cap Growth ETF
IWP
$20.1B
$8.82M 0.32%
75,171
-54,819
-42% -$6.13M
VYM icon
54
Vanguard High Dividend Yield ETF
VYM
$81.4B
$8.66M 0.31%
67,584
-112
-0.2% -$13.8K
VZ icon
55
Verizon
VZ
$197B
$8.61M 0.31%
191,683
-53,551
-22% -$2.23M
CVX icon
56
Chevron
CVX
$385B
$8.46M 0.3%
57,435
-13,455
-19% -$2M
SPY icon
57
State Street SPDR S&P 500 ETF Trust
SPY
$806B
$8.4M 0.3%
14,640
-3,898
-21% -$2.16M
PEP icon
58
PepsiCo
PEP
$191B
$8.3M 0.3%
48,837
-14,681
-23% -$2.52M
AMGN icon
59
Amgen
AMGN
$204B
$8.28M 0.3%
25,702
+1,804
+8% +$590K
VTV icon
60
Vanguard Morningstar Value ETF
VTV
$189B
$8.21M 0.29%
47,044
+702
+2% +$118K
VBK icon
61
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.5B
$8.17M 0.29%
30,561
-3,959
-11% -$1.01M
CSCO icon
62
Cisco
CSCO
$457B
$7.99M 0.29%
150,215
-26,785
-15% -$1.3M
DE icon
63
Deere & Co
DE
$163B
$7.93M 0.28%
19,009
-2,036
-10% -$768K
PFE icon
64
Pfizer
PFE
$143B
$7.7M 0.28%
266,017
-76,703
-22% -$2.24M
BRK.B icon
65
Berkshire Hathaway Class B
BRK.B
$1.11T
$7.44M 0.27%
16,167
-2,184
-12% -$966K
VOE icon
66
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.8B
$7.4M 0.27%
44,111
-30,928
-41% -$4.92M
SUB icon
67
iShares Short-Term National Muni Bond ETF
SUB
$11.3B
$7.24M 0.26%
68,204
-17,276
-20% -$1.82M
JNJ icon
68
Johnson & Johnson
JNJ
$613B
$6.99M 0.25%
43,123
-7,843
-15% -$1.25M
IBTE
69
DELISTED
iShares iBonds Dec 2024 Term Treasury ETF
IBTE
$6.93M 0.25%
288,678
-2,672
-0.9% -$64K
IWS icon
70
iShares Russell Mid-Cap Value ETF
IWS
$15.7B
$6.79M 0.24%
51,333
-41,941
-45% -$5.3M
NVDA icon
71
NVIDIA
NVDA
$5.01T
$6.71M 0.24%
55,235
-30,083
-35% -$3.55M
LMT icon
72
Lockheed Martin
LMT
$135B
$6.67M 0.24%
11,410
-3,189
-22% -$1.71M
JPEM icon
73
JPMorgan Diversified Return Emerging Markets Equity ETF
JPEM
$390M
$6.6M 0.24%
116,574
+39,905
+52% +$2.18M
IWN icon
74
iShares Russell 2000 Value ETF
IWN
$14.5B
$6.34M 0.23%
37,986
-25,364
-40% -$4.12M
VOT icon
75
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.6B
$6.14M 0.22%
25,208
-7,462
-23% -$1.74M

Similar funds

Avantax Planning Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Avantax Planning Partners held 493 positions worth $2.79B, down 10% from $3.11B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Avantax Planning Partners withdrew a net $496M in Q3 2024, closing 50 positions and reducing 324 holdings. Its most notable exit was iShares iBonds Dec 2028 Term Corporate ETF, an estimated $2.14M position sold in full.

By sector, the portfolio is most concentrated in Technology at 4.7% of assets, down from 5% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Avantax Planning Partners opened a new position in Vertex Pharmaceuticals worth $397K.

  • Avantax Planning Partners's largest Q3 2024 buy was Vertex Pharmaceuticals: 854 shares worth $397K.
  • Avantax Planning Partners added most to JPMorgan International Bond Opportunities ETF in Q3 2024, an estimated $8.66M increase.
  • Avantax Planning Partners's biggest Q3 2024 reduction was Schwab US Large-Cap Growth ETF, cutting an estimated $59.3M.
  • Avantax Planning Partners fully exited iShares iBonds Dec 2028 Term Corporate ETF in Q3 2024, selling an estimated $2.14M.
  • Avantax Planning Partners's ten largest holdings make up 55% of its $2.79B portfolio in Q3 2024.
  • Avantax Planning Partners opened 23 new positions and closed 50 in Q3 2024.
  • Avantax Planning Partners's portfolio value fell 10% quarter-over-quarter to $2.79B.

Based on Avantax Planning Partners's 13F filing for Q3 2024, filed 14 Nov 2024.